Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Arthralgia × Tamoxifen × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 142 Carcinoma, Intraductal, Noninfiltrating 14 Breast Carcinoma In Situ 10 Neoplasm Metastasis 9 Breast Neoplasms, Male 7 Ovarian Neoplasms 6 Neoplasms 4 Inflammatory Breast Neoplasms 3 Glioblastoma 3 Breast Cancer Female 3 Urinary Bladder Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Obesity 2 Hot Flashes 2 Fibroadenoma 2 Endometrial Neoplasms 2 ER+ Breast Cancer 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1 Sexuality 1 Risk Reduction Behavior 1 Primary Breast Cancer 1 Premenopausal Breast Cancer 1 Precancerous Conditions 1 Patient Acceptance of Health Care 1 Oligodendroglioma 1

Interventions

Letrozole 4 Surveys and Questionnaires 3 Aromatase Inhibitors 3 Anastrozole 3 exemestane 2 Exercise 2 Acupuncture Therapy 2 methyl hydroxyethyl cellulose 1 guizhi-shaoyao-zhimu decoction 1 Yoga 1 Walking 1 Vitamin B 12 1 Therapeutics 1 Testosterone 1 Tamoxifen 1 Occupational Therapy 1 Hyaluronic Acid 1 Glucosamine 1 Glucaric Acid 1 Gabapentin 1 Fish Oils 1 Fatty Acids, Omega-3 1 Educational Status 1 Docosahexaenoic Acids 1 Diphosphonates 1 Diet Therapy 1 Denosumab 1 Curcumin 1 Chondroitin Sulfates 1 Chondroitin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01896050 2016-06-28

LOGRIBMET

University of Michigan Rogel Cancer Center

115 enrolled 14 charts

Breast Neoplasms, Obesity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡